Biography
Scott Siegel, Ph.D., MHCDS is a licensed psychologist and the Director of Cancer Control & Population Sciences within the Helen F. Graham Cancer Center & Research Institute at ChristianaCare. In this role, Dr. Siegel works collaboratively with multidisciplinary teams in the health system and with government, academic, and community-based partners to reduce the overall burden of cancer and advance health equity.
Areas of Expertise (7)
Cancer and Behavioral Health
Population Health Research
Behavioral Health Determinants
Psychchology
Social Health Determinants
Psychosocial Oncology
Research Education
Education (3)
Dartmouth College: Master of Health Care Delivery Science 2018
University of Miami: Ph.D, Clinical Health Psychology 2007
University of Miami: MS, Clinical Health Psychology 2003
Multimedia
Publications:
Documents:
Links and Image Galleries (1)
Media Appearances (4)
COVID-19 testing and Population Health Research
New Castle County Government Facebook Live online
County Executive Matt Meyer is joined by ChristianaCare’s Dr. Scott Siegel at our #COVID19 testing site at Conrad Schools of Science to discuss the County’s testing initiative. Our Wilmington University site has been closed because of thunderstorm risks and the Conrad site has been moved indoors. Anyone registered for Wilmington University is welcome to come to Conrad instead or any of our other sites this weekend or next week. To view sites and register, visit Delaware.curativeinc.com
Coping After Breast Cancer
UDAILY online
2020-05-12
Shortly after arriving at UD in 2005, Laurenceau began collaborating with Scott Siegel, a clinical health psychologist who practices in the cancer center and director of Population Health Research at ChristianaCare’s Value Institute. Laurenceau and Siegel noticed that fear of cancer recurrence was a common clinical problem reported by cancer patient...
Christiana Care doctors examine gene editing to improve patient response to lung cancer treatments
Delaware Public Media online
2018-04-16
Scott Siegel, the director of population health psychology at Christiana Care’s Value Institute, says doctors want to reduce the burden of lung cancer on members in the community...
INBRE: funding $18.2 million NIH grant supports Delaware INBRE biomedical research efforts
UDAILY online
2014-09-19
“We’re improving patient care with the work that’s going on here,” said Scott Siegel, director of cancer psychology at the Helen F. Graham Cancer Center and Research Institute and an INBRE principal investigator for Christiana Care Health System. “Students are getting the experiences they need out of this, but we as institutions are benefiting directly.”
Selected Papers and Publications (6)
The co-occurrence of smoking and alcohol use disorder in a hospital-based population: Applying a multimorbidity framework using geographic information system methods Authors
Addictive Behaviors2021 Tobacco and alcohol use are leading causes of premature mortality in the US and concurrent use is associated with even greater health risks. A cross-sectional study of 20,310 patients admitted to a Mid-Atlantic acute health care system between July 1, 2018 and June 30, 2019 were categorized according to smoking and alcohol use disorder (AUD) status.
Characterizing the spatial relationship between smoking status and tobacco retail exposure: Implications for policy development and evaluation
Health & Place2021 Tobacco retail density and smoking prevalence remain elevated in marginalized communities, underscoring the need for strategies to address these place-based disparities. The spatial variation of smokers and tobacco retailers is often measured by aggregating them to area-level units (e.g., census tracts), but spatial statistical methods that use point-level data, such as spatial intensity and K-functions, can better describe their geographic patterns.
Operationalizing the Population Health Framework: Clinical Characteristics, Social Context, and the Built Environment
Population Health Management2020-10-13
As a framework, population health emphasizes health outcomes for entire populations, the broad range of determinants of these outcomes, and the comparative effectiveness of medical and public health interventions. In practice, however, many contemporary population health programs instead focus on small subsets of patients who account for a disproportionate share of health care utilization, often with disappointing results.
Assessing the relationship between fear of cancer recurrence and health care utilization in early-stage breast cancer survivors
Journal of Cancer Survivorship2018-10-19
The purpose of this study was to determine whether fear of cancer recurrence (FCR) is associated with greater health care utilization (HCU) in early-stage breast cancer survivors.Three hundred early-stage breast cancer survivors diagnosed within the past 7 years reported on FCR as well as calls and visits to oncology providers and primary care providers during the preceding 3 months. Participants also reported on use of mental health services and psychotropic medications since diagnosis.
Does sharing good news buffer fear of bad news? A daily diary study of fear of cancer recurrence in couples approaching the first mammogram post‐diagnosis
Psycho-Oncology2018-06-21
The core of fear of cancer recurrence (FCR)—a top concern of couples after successful breast cancer (BC) treatment—is fear of death. Daily relationship processes may be instrumental in regulating FCR as triggers of existential distress are encountered. We tested the hypothesis that daily capitalization, the process of sharing good news (capitalization attempts) to a partner perceived as responsive (responsiveness), buffers patient and spouse FCR as they confront the first mammogram post‐diagnosis.
Social constraints and fear of recurrence in couples coping with early stage breast cancer
Health Psychology2018 Fear of cancer recurrence (FCR) is a top concern of breast cancer (BC) survivors and their spouses. FCR often occurs within an interpersonal context, yet there has been little research on relationship processes that may influence FCR in patients and spouses.